Neuroblastoma Cell Lines
Neuroblastoma Cell Lines - Related Videos
05:08
Differentiation of a Human Neuroblastoma Cell Line into Mature Neurons
0 Views •
2025
This video demonstrates a technique for transforming undifferentiated SH-SY5Y neuroblastoma cells into fully differentiated mature neurons using a systematic passaging technique. This involves culturing the cells in a series of media with gradually decreasing serum levels to inhibit the proliferation of epithelial-like cells while promoting the differentiation and proliferation of neuron-like cells. Additionally, the media is supplemented with retinoic acid and specific growth factors that...
02:33
Assessing Atmospheric Pressure Plasma Treatment in Glucose-Deprived Neuroblastoma Cells
0 Views •
2025
Source: Yan, X., et. al., New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells. J. Vis. Exp. (2017)The video demonstrates the neuroprotective activity of low-dose atmospheric pressure plasma treatment in glucose-deprived neuroblastoma cells by modulating oxidative stress and enhancing cell viability.
06:23
Microglial Phagocytosis Assay: An In Vitro Assay to Establish Microglial Phagocytosis Model for Neuroblastoma Cells Using iPSC Macrophages
0 Views •
2023
In this video, we perform the microglial phagocytosis assay for neuroblastoma using induced pluripotent stem cells. The assay helps assess the impairment of microglial function in neurodegenerative diseases.
08:07
Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
0 Views •
Cited by 466 •
2016
It is critical in neurobiology and neurovirology to have a reliable, replicable in vitro system that serves as a translational model for what occurs in vivo in human neurons. This protocol describes how to culture and differentiate SH-SY5Y human neuroblastoma cells into viable neurons for use in in vitro applications.
07:48
Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds
0 Views •
Cited by 9 •
2021
This paper lists the steps required to seed neuroblastoma cell lines on previously described three-dimensional collagen-based scaffolds, maintain cell growth for a predetermined timeframe, and retrieve scaffolds for several cell growth and cell behavior analyses and downstream applications, adaptable to satisfy a range of experimental aims.
FAQs
MYCN amplification can serve as a molecular variable when interpreting neuroblastoma cell behavior. Because some lines carry this alteration and others do not, researchers can relate differences in growth, signaling, differentiation, apoptosis, or treatment response to distinct genetic backgrounds. This comparison helps prevent conclusions from one line being treated as universal.
Neuronal differentiation potential allows investigators to examine how neuroblastoma cells change from an abnormal growth state toward a more neuron-like state. Measuring this process alongside proliferation and apoptosis connects cell identity with survival and expansion. The model therefore supports studies of developmental biology and treatments intended to alter tumor-cell behavior.
Signaling pathways, proliferation, apoptosis, and differentiation represent complementary biological readouts rather than interchangeable outcomes. A pathway study can indicate how cellular signals operate, while proliferation measures expansion, apoptosis reflects programmed cell death, and differentiation tracks altered cell state. Using these endpoints together gives a more complete interpretation of how a perturbation affects tumor biology.
Controlled culture conditions are important because they make observations more reproducible across experiments. Neuroblastoma cell lines can be maintained under controlled laboratory conditions, allowing researchers to examine the same cellular model repeatedly while changing the question or treatment being tested. This consistency supports comparisons of growth, differentiation, apoptosis, and treatment response.
Researchers can assess anticancer treatments in neuroblastoma cell lines by examining changes in proliferation, apoptosis, differentiation, or signaling. These measurements show whether a candidate treatment produces a detectable cellular effect, while responses across lines reveal how molecular differences may shape sensitivity. The approach supports early comparison of therapeutic candidates in pediatric cancer research.
Comparing several lines is especially useful when a result may depend on molecular context. Lines with different genetic alterations or other molecular profiles can produce contrasting outcomes under the same experimental question. Such variation helps researchers distinguish a broadly observed mechanism from a cell-line-specific effect and informs more precise disease modeling.